Mode
Text Size
Log in / Sign up
N/A Completed N=26 Treatment

Reaching and Engaging Depressed Senior Center Clients

Depression in Old Age
Source: ClinicalTrials.gov NCT04289298 ↗
Enrolled (actual)
26
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcomePrimary: Number of Virtual ENGAGE-A Participants Who Attend Every Scheduled Therapy Session — 17 Participants

Summary

The purpose of this study is to test the feasibility of one type of therapy session, Virtual Augmented Engage (Engage-A). The research is being done because the researchers are trying to learn if these approaches could be used by therapists in the community social service agencies to treat older adults with depression. The research will also measure clinician satisfaction after training and supervision of utilization of Engage-A.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Virtual ENGAGE-A Participants Who Attend Every Scheduled Therapy Session
17
PRIMARY
Change in Average Satisfaction Score of Virtual ENGAGE-A Participants as Measured by the CSQ
2.5; 2.89; 2.83; 2.5; 3.31; 3.33
PRIMARY
Average Satisfaction Score of Community Clinicians (LCSW) as Measured by the TSQ
4.0; 4.0; 4.0
SECONDARY
Change in Depressive Symptoms of Virtual ENGAGE-A Participants as Measured by HAM-D
21.24; 14.47; 11.19; 11.67
SECONDARY
Change in Behavioral Activation of Virtual ENGAGE-A Participants as Measured by the BADS
18.62; 22.50; 13.76; 20.25; 24.67; 27.94

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 55 years' old
  • PHQ-9 Score of ≥ 10
  • English or Spanish speaking
  • MOCA ≥ 24 or mini-telephone MOCA ≥ 11
  • Member of/attends one of the REDS Senior Centers
  • Capacity to provide written consent for both research assessment and the Engage-A intervention.

Exclusion Criteria

  • Current active suicidal ideation defined by MADRS Suicide Item ≥ 4 (probably better off dead. Suicidal thoughts are common, and suicide is considered as a possible solution, but without specific plans or intention).
  • Presence of psychiatric diagnoses other than unipolar, non-psychotic major depression or generalized anxiety disorder by SCID-IV.
  • Severe or life-threatening medical illness (e.g., end stage organ failure).
  • Currently seeing an individual psychotherapist *(if individuals are willing to go on a hiatus from their individual psychotherapist for the 15 weeks of the study, and meet all inclusion criteria, they will be considered eligible).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04289298). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search